110 related articles for article (PubMed ID: 955241)
1. Vasoconstriction in response to corticosteroids observed in human lips.
Stüttgen G
Dermatologica; 1976; 152 Suppl 1():91-100. PubMed ID: 955241
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid ointments: comparison by two human bioassays.
Burdick KH; Haleblian JK; Poulsen BJ; Cobner SE
Curr Ther Res Clin Exp; 1973 May; 15(5):233-42. PubMed ID: 4196783
[No Abstract] [Full Text] [Related]
3. Objective measurement of topically applied corticosteroids.
Király K; Soós G
Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
[TBL] [Abstract][Full Text] [Related]
4. Studies of the mechanisms by which cells become resistant to corticosteroids.
Berliner DL
Cancer Res; 1965 Aug; 25(7):1085-95. PubMed ID: 5214994
[No Abstract] [Full Text] [Related]
5. Effects of corticosteroids on fibroblast functions.
Berliner DL; Nabors CJ
J Reticuloendothel Soc; 1967 Jul; 4(4):284-313. PubMed ID: 6056840
[No Abstract] [Full Text] [Related]
6. [Corticosteroid effect and vasoconstriction. 2. Influencing the antipsoriatic corticosteroid effect by suppression of vasoconstriction].
Maucher OM; Brehm K
Arzneimittelforschung; 1972 Jun; 22(6):1039-43. PubMed ID: 4559155
[No Abstract] [Full Text] [Related]
7. [Corticosteroid effect and vasoconstriction. 1. Suppression of corticosteroid-induced vasoconstriction in the healthy skin by tolazoline].
Brehm K; Maucher OM
Arzneimittelforschung; 1972 Jun; 22(6):1038-9. PubMed ID: 5068352
[No Abstract] [Full Text] [Related]
8. [Comparative studies on the vasoconstrictor effect of various corticosteroids].
Bickhardt R
Hautarzt; 1972 Jul; 23(7):301-5. PubMed ID: 4655109
[No Abstract] [Full Text] [Related]
9. The effect of constituents in white soft paraffin on the efficacy of corticosteroid ointments in the vasoconstrictor test.
Coldman MF; Lockerbie L
J Pharm Pharmacol; 1971 Dec; 23():253S-254S. PubMed ID: 4401514
[No Abstract] [Full Text] [Related]
10. Percutaneous corticosteroid absorption correlated to partition coefficient.
Katz M; Shaikh ZI
J Pharm Sci; 1965 Apr; 54(4):591-4. PubMed ID: 5842347
[No Abstract] [Full Text] [Related]
11. Extemporaneous formulation of corticosteroids for topical usage.
Burdick KH; Poulsen B; Place VA
JAMA; 1970 Jan; 211(3):462-6. PubMed ID: 5466919
[No Abstract] [Full Text] [Related]
12. Plethysmographic recordings of skin pulses. IV. The vasoconstrictive effect of steroids in normal and stripped skin.
Thune P
Acta Derm Venereol; 1971; 51(4):261-7. PubMed ID: 4105772
[No Abstract] [Full Text] [Related]
13. Relation of capillary resistance and adrenal corticosteroids; stress-induced changes in the sensitivity of capillaries to corticosteroids.
KRAMAR J; SIMAY-KRAMAR M; CARNAZZO AJ
J Appl Physiol; 1958 Sep; 13(2):257-62. PubMed ID: 13575340
[No Abstract] [Full Text] [Related]
14. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
Barry BW; Woodford R
Br J Dermatol; 1974 Sep; 91(3):323-38. PubMed ID: 4611447
[No Abstract] [Full Text] [Related]
15. Effect of fluocinolone acetonide cream on human skin blood flow.
Chimoskey JE; Holloway GA; Flanagan WJ
J Invest Dermatol; 1975 Aug; 65(2):241-3. PubMed ID: 1151118
[TBL] [Abstract][Full Text] [Related]
16. The cutaneous corticosteroid vasoconstriction assay: a reflectance spectroscopic and laser-Doppler flowmetric study.
Andersen P; Milioni K; Maibach H
Br J Dermatol; 1993 Jun; 128(6):660-5. PubMed ID: 8338750
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous steroid absorption in anhidrosis.
Solomon LM; Altman AT
J Invest Dermatol; 1969 Dec; 53(6):454-7. PubMed ID: 5361579
[No Abstract] [Full Text] [Related]
18. The effects of corticosteroids on the responses of the anococcygeus and gastrocnemius muscles to nerve stimulation in the pithed rat [proceedings].
Gibson A; Pollock D; Spence JC
Br J Pharmacol; 1976 Oct; 58(2):302P-303P. PubMed ID: 974417
[No Abstract] [Full Text] [Related]
19. Various vagaries of vasoconstriction.
Burdick KH
Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376
[No Abstract] [Full Text] [Related]
20. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
Smith EB; Gregory JF; Bartruff JK
South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
